Overview

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

Status:
Terminated
Trial end date:
2017-03-31
Target enrollment:
Participant gender:
Summary
Multi-centre, randomised, open-label, placebo-controlled, two-period crossover study of 4 hour pH monitoring following a refluxogenic meal and drink.
Phase:
Phase 3
Details
Lead Sponsor:
Reckitt Benckiser Healthcare (UK) Limited
Treatments:
Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
Alginic acid